Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table 3 from Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine
  1. Home
  2. Publications
  3. Supplementary Table 3 from Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine

Supplementary Table 3 from Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine

Authors:
  • ECEvan C. Chen
    Evan C. Chen
  • YLYiwen Liu
    Yiwen Liu
  • HBHayden L. Bell
    Hayden L. Bell
  • JRJeremy Ryan
    Jeremy Ryan
  • JWJason Wu
    Jason Wu
  • EMEmma-Jayne Minihane
    Emma-Jayne Minihane
  • MLMarlise R. Luskin
    Marlise R. Luskin
  • EWEric S. Winer
    Eric S. Winer
  • RVRahul Vedula
    Rahul Vedula
  • VVVirginia Volpe
    Virginia Volpe
  • MSMaximilian Stahl
    Maximilian Stahl
  • DRDaniel Roberts
    Daniel Roberts

Open Access
Publisher website
Google Scholar
  • 14 August 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.33253178
Abstract
Table S3: Patient-by-patient characteristics.
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE I CLINICAL TRIALS
  • CLINICAL-STAGE RESEARCH
  • DRUG MECHANISMS
  • DRUG-MEDIATED STIMULATION OF CELL DEATH PATHWAYS
  • DRUG TARGETS
  • HEMATOLOGICAL CANCERS
  • LEUKEMIAS
  • PRECISION MEDICINE
  • SMALL MOLECULE AGENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.